The Royal Marsden and The Institute of Cancer Research (ICR) work as one integrated organisation to rapidly move science from bench to bedside.
This relationship provides a privileged framework from which to apply knowledge about the basic science of cancer to translational research and clinical practice. This leads to:
- an improved understanding of the molecular development of cancer
- advancement in the identification of new drug targets
- better outcomes through personalised treatment for patients with cancer.
The partnership between The Royal Marsden and the ICR has been further strengthened with the appointment in July 2009 of Professor David Cunningham and Professor Alan Ashworth as Co-Directors of Research Integration for both organisations.
They will help to ensure that basic research at the ICR has a rapid impact in Royal Marsden clinics, and that the strengths of the hospital in clinical trials and research impact the research strategy and agenda for both organisations.